A Prospective Observational Study in COPD Patients Evaluating the Quality of Life in Patients Switching From a Dual Therapy to a Fixed LAMA/LABA/ICS Triple Therapy in Routine Practice
Latest Information Update: 14 Dec 2021
At a glance
- Drugs Beclometasone/formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms TRISNOOZE
- Sponsors Chiesi
- 25 Nov 2021 Status changed from recruiting to discontinued.
- 25 Nov 2021 Status changed from recruiting to discontinued.
- 11 Feb 2021 Planned number of patients changed from 1000 to 800.